Blog

If you are bequeathing wealth, you’ll not only be faced with a decision of who should receive it—children, charities, friends, siblings, etc.—but also the dilemma of the best way to transfer those assets, in what amounts and when. Regardless of who will...

Amid changes in the geopolitical order, the BRICS association is attempting to chart a new course. This article explains why its members—including the Eurasian troika of China, Russia, and India—believe a new multipolar world order is inevitable.

Collections from U.S. tariffs are surging. As legal uncertainty looms and costs gradually pass through, balancing resilient corporate fundamentals against policy risks remains crucial for portfolio positioning.

Did you know that you could become incapable of caring for yourself at any time? Jump on this video for more insights https://www.rbcwealthmanagement.com/en-ca/insights/video-what-does-incapacity-mean Let connect! Chris McManus

Well, what if the beneficiaries are six and nine years old? Or what if the beneficiary is disabled and unable to manage the monies on their own? Or what if one of the potential beneficiaries battles addiction issues? Jump on this video to find out? https://www...

One clear winner from the Fed’s 25 basis point rate cut was the U.S. Treasury, which can roll over maturing debt at lower costs. Lower rates alone, however, are unlikely to make the country’s fiscal policy sustainable.

The number of extreme family fallouts that has been shared with me is heartbreaking. “I no longer speak to my brother.” “The cousins won’t be at the same wedding.” “Oh my gosh, we ended up taking my stepsister to court.” And so on and so on and so on...

With the Fed poised to lower overnight interest rates next week, we think investors may be disappointed with what lowering rates is likely to accomplish. We look at the potential asset-class implications if the Fed moves too aggressively.

There’s more to a long life than simply a long lifespan. The number of years we spend in good health, or healthspan, is key. With biotech spurring promising medical innovations, we look at how it can fit into investment portfolios.